Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Elective	O
coronary	O
angiography	O
and	O
RHC	O
in	O
setting	O
of	O
dyspnea	O
on	O
exertion	O
and	O
___	O
edema	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Intubation	O
___	O
Extubate,	O
Re-intubated	O
___	O
Extubated	O
(___)	O
Central	O
line	O
placement	O
(___)	O
History	O
of	O
Present	O
Illness:	O
HISTORY	O
OF	O
PRESENTING	O
ILLNESS:	O
___	O
is	O
a	O
___	O
PMH	O
HFpEF,	O
inferior	O
MI,	O
HTN,	O
HLD,	O
CAD	O
(no	O
stents),	O
PVD	O
s/p	O
peripheral	O
stents,	O
bilateral	O
renal	O
artery	O
stenosis	O
s/p	O
stenting	O
in	O
___,	O
?multisystem	O
atrophy	O
who	O
presented	O
to	O
clinic	O
with	O
dyspnea	O
on	O
exertion	O
and	O
peripheral	O
edema.	O
His	O
home	O
Furosemide	O
dose	O
had	O
been	O
increased	O
from	O
20mg	O
daily	O
to	O
40mg	O
daily	O
with	O
some	O
improvement	O
in	O
his	O
edema,	O
but	O
no	O
improvement	O
in	O
his	O
dyspnea.	O
As	O
a	O
result	O
the	O
decision	O
was	O
made	O
for	O
him	O
to	O
have	O
a	O
R	O
and	O
LHC	O
for	O
further	O
workup.	O
He	O
presented	O
today	O
for	O
a	O
planned	O
outpatient	O
L	O
and	O
RHC.	O
He	O
was	O
found	O
to	O
have	O
multivessel	O
disease	O
non	O
amenable	O
to	O
PCI,	O
felt	O
not	O
to	O
be	O
good	O
CABG	O
candidate	O
so	O
doing	O
medical	O
management.	O
R	O
sided	O
pressures	O
up,	O
also	O
wheezing	O
throughout	O
procedure.	O
RHC	O
numbers	O
-	O
RA	O
18,	O
RV	O
60/20,	O
PCWP	O
38,	O
mPAP	O
42.	O
Had	O
right	O
radial	O
access.	O
On	O
arrival	O
to	O
the	O
floor	O
he	O
says	O
that	O
he	O
is	O
not	O
having	O
any	O
CP,	O
arm	O
pain,	O
jaw	O
pain,	O
nausea,	O
vomiting,	O
abdominal	O
pain.	O
He	O
is	O
endorsing	O
SOB	O
and	O
cough.	O
He	O
says	O
that	O
the	O
SOB	O
actually	O
feels	O
better	O
when	O
he	O
lies	O
down.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Hypertension	O
-	O
Dyslipidemia	O
2.	O
CARDIAC	O
HISTORY	O
-	O
EF	O
62%	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
-PVD,	O
b/l	O
SFA	O
disease	O
with	O
occluded	O
Rt	O
CIA,	O
CRI,	O
-bilateral	O
renal	O
artery	O
stenting	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death.	O
His	O
mother	O
has	O
___	O
disease.	O
Father	O
died	O
at	O
age	O
___	O
of	O
heart	O
failure.	O
Physical	O
Exam:	O
========================================	O
ADMISSION	O
EXAM	O
========================================	O
VS:	O
98.5	O
145	O
/	O
72	O
70	O
22	O
97	O
ra	O
GENERAL:	O
NAD,	O
appears	O
stated	O
age,	O
sitting	O
up	O
in	O
bed	O
HEENT:	O
atramautic,	O
normocephalic,	O
EOMI,	O
PERRL	O
NECK:	O
Supple.	O
JVP	O
at	O
the	O
angle	O
of	O
the	O
jaw	O
CARDIAC:	O
RRR,	O
no	O
murmurs,	O
rubs,	O
gallops	O
LUNGS:	O
diffuse	O
inspiratory	O
and	O
expiratory	O
wheezes	O
throughout	O
all	O
lung	O
fields,	O
bibasilar	O
crackles	O
ABDOMEN:	O
NABS,	O
soft,	O
NT,	O
ND,	O
no	O
rebound	O
or	O
guarding	O
EXTREMITIES:	O
Warm,	O
well	O
perfused.	O
No	O
clubbing,	O
cyanosis,	O
or	O
peripheral	O
edema.	O
NEURO:	O
AAOx3,	B-Delirium
CN	O
II-XII	O
grossly	O
intact,	O
moving	O
all	O
4	O
extremities	O
spontaneously	O
and	O
with	O
purpose	O
==========================================	O
DISCHARGE	O
EXAM	O
==========================================	O
Vitals:	O
97.7	O
123/78	O
83	O
20	O
100%	O
Nebulizer	O
GENERAL:	O
Pleasant	O
elderly	O
gentleman	O
sitting	O
comfortably	O
in	O
bed	O
in	O
no	O
acute	O
distress	O
HEENT:	O
NCAT,	O
MMM,	O
EOMI,	O
no	O
scleral	O
icterus,	O
ecchymoses	O
around	O
neck	O
with	O
mild	O
neck	O
swelling	O
but	O
no	O
LAD	O
or	O
hematoma	O
palpated	O
NECK:	O
Neck	O
veins	O
flat,	O
JVP	O
not	O
elevated,	O
no	O
JVD	O
HEART:	O
Irregularly	O
irregular,	O
no	O
m/r/g	O
LUNGS:	O
Mild	O
crackles	O
at	O
lung	O
bases	O
bilaterally	O
but	O
otherwise	O
CTAB,	O
upper	O
airway	O
sounds	O
transmitted	O
to	O
upper	O
lung	O
fields.	O
Does	O
appear	O
to	O
be	O
coughing	O
more.	O
ABDOMEN:	O
Soft,	O
NT/ND,	O
BS+	O
EXTREMITIES:	O
WWP,	O
no	O
lower	O
extremity	O
edema	O
PULSES:	O
2+	O
DP	O
pulses	O
bilaterally	O
NEURO:	O
Grossly	O
intact	O
SKIN:	O
warm	O
and	O
well	O
perfused,	O
no	O
excoriations	O
or	O
lesions,	O
no	O
rashes,	O
bruising	O
on	O
arms	O
and	O
anterior	O
neck	O
Pertinent	O
Results:	O
==============	O
ADMISSION	O
LABS	O
==============	O
___	O
06:45PM	O
BLOOD	O
WBC-6.2	O
RBC-4.22*	O
Hgb-13.2*	O
Hct-40.2	O
MCV-95	O
MCH-31.3	O
MCHC-32.8	O
RDW-13.4	O
RDWSD-46.1	O
Plt	O
___	O
___	O
06:45PM	O
BLOOD	O
Plt	O
___	O
___	O
06:45PM	O
BLOOD	O
Glucose-111*	O
UreaN-31*	O
Creat-1.2	O
Na-139	O
K-4.9	O
Cl-103	O
HCO3-25	O
AnGap-11	O
___	O
06:45PM	O
BLOOD	O
Calcium-8.6	O
Phos-4.1	O
Mg-2.0	O
___	O
02:57AM	O
BLOOD	O
___	O
pO2-47*	O
pCO2-53*	O
pH-7.36	O
calTCO2-31*	O
Base	O
XS-2	O
=============================	O
PERTINENT	O
RESULTS	O
=============================	O
IMAGING/STUDIES	O
=============================	O
CARDIAC	O
CATH:	O
___	O
1.	O
Severe	O
3	O
vessel	O
CAD	O
(see	O
description)	O
2.	O
Markedly	O
elevated	O
L	O
and	O
R	O
sided	O
fillling	O
pressures	O
with	O
low	O
normal	O
mcardiac	O
index.	O
Severe	O
pulmonary	O
hypetension	O
with	O
only	O
minimally	O
elevated	O
PVR.	O
Recommendations	O
1.	O
He	O
is	O
not	O
a	O
good	O
candidate	O
for	O
CABG	O
based	O
on	O
clinical	O
history.	O
PCI	O
options	O
might	O
include	O
attempted	O
CTO	O
of	O
RCA	O
and	O
then	O
consider	O
PCI	O
of	O
LAD	O
(diffuse	O
area	O
for	O
stenting)	O
and	O
stent	O
of	O
D1/Ramus.	O
This	O
would	O
be	O
complex	O
and	O
is	O
dependent	O
on	O
successful	O
CTO.	O
For	O
now	O
he	O
requires	O
treatment	O
for	O
heart	O
failure	O
before	O
consideration	O
of	O
PCI.	O
===	O
CXR	O
___	O
IMPRESSION:	O
Compared	O
to	O
chest	O
radiographs	O
since	O
___	O
most	O
recently	O
___.	O
Lung	O
volumes	O
are	O
lower	O
with	O
more	O
basal	O
atelectasis	O
and	O
crowding	O
of	O
pulmonary	O
vasculature	O
that	O
might	O
obscure	O
mild	O
pulmonary	O
edema.	O
Mediastinal	O
veins	O
are	O
but	O
not	O
overly	O
engorged.	O
Heart	O
is	O
partially	O
obscured	O
by	O
the	O
elevated	O
diaphragm,	O
but	O
not	O
massive.	O
Pleural	O
effusions	O
are	O
small	O
if	O
any.	O
No	O
pneumothorax.	O
===	O
Lower	O
extremity	O
US	O
___	O
No	O
evidence	O
of	O
deep	O
venous	O
thrombosis	O
in	O
the	O
left	O
lower	O
extremity	O
veins.	O
===	O
Chest	O
CT	O
___	O
IMPRESSION:	O
Bibasilar,	O
dependent	O
atelectasis.	O
Otherwise	O
no	O
acute	O
intrathoracic	O
abnormality.	O
===	O
Neck	O
CT	O
___	O
IMPRESSION:	O
1.	O
Fluid	O
surrounding	O
the	O
endotracheal	O
tube	O
in	O
the	O
subglottic	O
region.	O
No	O
evidence	O
of	O
airway	O
narrowing	O
or	O
obstruction.	O
2.	O
Please	O
refer	O
to	O
separate	O
report	O
of	O
CT	O
chest	O
performed	O
on	O
the	O
same	O
day	O
for	O
description	O
of	O
the	O
thoracic	O
findings.	O
===	O
CXR	O
___.	O
No	O
pneumonia.	B-Lower_respiratory_tract_infection
2.	O
New	O
mild	O
right	O
lower	O
lobe	O
atelectasis.	O
3.	O
Moderate	O
left	O
lower	O
lobe	O
atelectasis,	O
improved.	O
4.	O
Small	O
left	O
pleural	O
effusion.	O
===	O
TTE	O
___	O
Very	O
suboptimal	O
image	O
quality.	O
The	O
left	O
atrium	O
is	O
mildly	O
dilated.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
The	O
left	O
ventricular	O
cavity	O
is	O
unusually	O
small.	O
Due	O
to	O
suboptimal	O
technical	O
quality,	O
a	O
focal	O
wall	O
motion	O
abnormality	O
cannot	O
be	O
fully	O
excluded	O
(posterobasal	O
segment	O
may	O
be	O
hypokinetic	O
or	O
akinetic).	O
Left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic	O
(EF	O
=	O
80%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
number	O
of	O
aortic	O
valve	O
leaflets	O
cannot	O
be	O
determined.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
(?#).	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
An	O
eccentric,	O
posteriorly	O
directed	O
jet	O
of	O
at	O
least	O
moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
Due	O
to	O
the	O
eccentric	O
nature	O
of	O
the	O
regurgitant	O
jet,	O
its	O
severity	O
may	O
be	O
significantly	O
underestimated	O
(Coanda	O
effect).	O
Moderate	O
[2+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
The	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.The	O
mitral	O
regurgitation	O
is	O
almost	O
certainly	O
significantly	O
underestimated	O
due	O
to	O
eccentric	O
nature	O
of	O
flow	O
as	O
well	O
as	O
very	O
suboptimal	O
image	O
quality.	O
TEE	O
recommended	O
for	O
better	O
assessment	O
if	O
clinically	O
indicated.	O
=============================	O
MICROBIOLOGY	O
=============================	O
__________________________________________________________	O
___	O
12:37	O
pm	O
BRONCHIAL	O
WASHINGS	O
BRONCHIAL	O
WASH.	O
**FINAL	O
REPORT	O
___	O
GRAM	O
STAIN	O
(Final	O
___:	O
4+	O
(>10	O
per	O
1000X	O
FIELD):	O
POLYMORPHONUCLEAR	O
LEUKOCYTES.	O
1+	O
(<1	O
per	O
1000X	O
FIELD):	O
GRAM	O
POSITIVE	O
ROD(S).	O
2+	O
___	O
per	O
1000X	O
FIELD):	O
GRAM	O
POSITIVE	O
COCCI.	O
IN	O
SHORT	O
CHAINS.	O
RESPIRATORY	O
CULTURE	O
(Final	O
___:	O
10,000-100,000	O
CFU/mL	O
Commensal	O
Respiratory	O
Flora.	O
KLEBSIELLA	O
PNEUMONIAE.	O
10,000-100,000	O
CFU/mL.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
KLEBSIELLA	O
PNEUMONIAE	O
|	O
AMPICILLIN/SULBACTAM--	O
4	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
__________________________________________________________	O
___	O
10:20	O
pm	O
BLOOD	O
CULTURE	O
Source:	O
Line-CL.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
__________________________________________________________	O
___	O
8:13	O
am	O
BLOOD	O
CULTURE	O
Source:	O
Venipuncture.	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
==========================	O
DISCHARGE	O
LABS	O
==========================	O
___	O
07:15AM	O
BLOOD	O
WBC-17.0*	O
RBC-3.64*	O
Hgb-11.6*	O
Hct-35.3*	O
MCV-97	O
MCH-31.9	O
MCHC-32.9	O
RDW-13.9	O
RDWSD-48.2*	O
Plt	O
___	O
___	O
07:15AM	O
BLOOD	O
Plt	O
___	O
___	O
07:15AM	O
BLOOD	O
Glucose-109*	O
UreaN-65*	O
Creat-1.3*	O
Na-140	O
K-4.1	O
Cl-99	O
HCO3-28	O
AnGap-13	O
___	O
07:15AM	O
BLOOD	O
Calcium-8.5	O
Phos-4.7*	O
Mg-2.___	O
is	O
a	O
___	O
PMH	O
HFpEF,	O
inferior	O
MI,	O
HTN,	O
HLD,	O
3VD	O
CAD	O
(no	O
stents),	O
PVD	O
s/p	O
peripheral	O
stents,	O
bilateral	O
renal	O
artery	O
stenosis	O
s/p	O
stenting	O
in	O
___,	O
?multisystem	O
atrophy	O
who	O
presented	O
to	O
clinic	O
with	O
dyspnea	O
on	O
exertion	O
and	O
peripheral	O
edema	O
s/p	O
R	O
and	O
LHC	O
showing	O
3v	O
coronary	O
artery	O
disease	O
and	O
elevated	O
right	O
sided	O
filling	O
pressures.	O
His	O
hospital	O
course	O
was	O
complicated	O
by	O
acute	O
hypoxemic/hypercarbic	O
respiratory	O
failure,	O
acute	O
on	O
chronic	O
diastolic	O
heart	O
failure,	O
Klebsiella	O
pneumonia,	B-Lower_respiratory_tract_infection
and	O
new-onset	O
atrial	O
fibrillation.	O
=================	O
ACTIVE	O
ISSUES	O
=================	O
#	O
Acute	O
hypoxemic/hypercarbic	O
respiratory	O
failure:	O
The	O
patient	O
presented	O
with	O
dyspnea	O
after	O
elective	O
cardiac	O
catheterization	O
showing	O
elevated	O
right-sided	O
filling	O
pressures.	O
He	O
was	O
initially	O
admitted	O
to	O
the	O
cardiology	O
service,	O
where	O
was	O
diuresed.	O
However,	O
his	O
dyspnea	O
persisted	O
and	O
he	O
developed	O
an	O
inspiratory	O
stridor	O
so	O
he	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
where	O
he	O
was	O
intubated.	O
Bronchoscopy	O
was	O
performed	O
that	O
showed	O
significant	O
expiratory	O
airway	O
collapse	O
consistent	O
with	O
tracheobronchomalacia.	O
Bronchial	O
washings	O
grew	O
Klebsiella,	O
and	O
the	O
patient	O
was	O
treated	O
with	O
a	O
5-day	O
course	O
of	O
ceftriaxone	O
and	O
azithromycin.	O
He	O
failed	O
his	O
first	O
attempt	O
at	O
extubation	O
due	O
to	O
inspiratory	O
stridor.	O
He	O
was	O
given	O
steroids	O
to	O
treat	O
airway	O
edema	O
and	O
was	O
successfully	O
extubated	O
on	O
the	O
second	O
attempt.	O
By	O
day	O
of	O
discharge,	O
he	O
was	O
saturation	O
well	O
and	O
breathing	O
comfortably	O
on	O
room	O
air.	O
#Acute	O
on	O
chronic	O
HFpEF:	O
Last	O
TTE	O
___	O
showed	O
preserved	O
EF	O
(62%).	O
RHC	O
showed	O
elevated	O
filling	O
pressures	O
with	O
RA	O
18,	O
RV	O
60/20,	O
PCWP	O
38,	O
mPAP	O
42,	O
consistent	O
with	O
volume	O
overload.	O
He	O
was	O
diuresed	O
to	O
euvolemia	O
and	O
restarted	O
on	O
furosemide	O
40	O
mg	O
daily.	O
Discharge	O
weight:	O
79.4	O
kg.	O
#Klebsiella	O
pneumonia:	B-Lower_respiratory_tract_infection
As	O
above,	O
BAL	O
grew	O
Klebsiella	O
and	O
the	O
patient	O
was	O
treated	O
with	O
a	O
course	O
of	O
ceftriaxone	O
and	O
azithromcyin.	O
#CAD:	O
Patient	O
underwent	O
left	O
and	O
right	O
cardiac	O
catheterization	O
that	O
showed	O
three-vessel	O
disease	O
and	O
elevated	O
right-sided	O
filling	O
pressures.	O
He	O
was	O
deemed	O
to	O
be	O
a	O
poor	O
candidate	O
for	O
CABG.	O
Medical	O
management	O
of	O
his	O
coronary	O
artery	O
disease	O
was	O
continued	O
with	O
aspirin,	O
atorvastatin,	O
and	O
metoprolol.	O
He	O
will	O
follow	O
up	O
with	O
his	O
outpatient	O
cardiologist	O
to	O
continue	O
optimal	O
medical	O
management,	O
and	O
to	O
discuss	O
any	O
possible	O
interventions	O
such	O
as	O
high-risk	O
PCI.	O
#Atrial	O
fibrillation:	O
Patient	O
diagnosed	O
with	O
new	O
atrial	O
fibrillation	O
during	O
this	O
admission.	O
He	O
was	O
started	O
on	O
metoprolol	O
and	O
apixaban.	O
#Steroid-induced	O
hyperglycemia:	O
Patient	O
was	O
given	O
steroids	O
for	O
inspiratory	O
stridor	O
and	O
airway	O
edema,	O
resulting	O
in	O
hyperglycemia.	O
He	O
was	O
given	O
insulin	O
to	O
treat	O
this.	O
His	O
blood	O
sugars	O
are	O
expected	O
to	O
normalize	O
after	O
discontinuation	O
of	O
steroids,	O
and	O
the	O
insulin	O
may	O
be	O
discontinued	O
at	O
that	O
time.	O
___:	O
Creatinine	O
on	O
presentation	O
was	O
1.2,	O
rose	O
to	O
a	O
peak	O
of	O
1.7,	O
and	O
was	O
1.3	O
on	O
day	O
of	O
discharge.	O
Thought	O
to	O
be	O
multifactorial,	O
with	O
contributions	O
from	O
contrast	O
nephropathy	O
and	O
cardiorenal	O
syndrome.	O
Acute	O
on	O
chronic	O
congestive	O
heart	O
failure	O
was	O
managed	O
as	O
above.	O
=================	O
CHRONIC	O
ISSUES	O
=================	O
#Urinary	O
retention:	O
Patient	O
performs	O
intermittent	O
straight	O
catheterizations	O
at	O
home	O
for	O
urinary	O
retention	O
secondary	O
to	O
BPH.	O
#OSA:	O
Continued	O
home	O
BIPAP.	O
=====================	O
TRANSITIONAL	O
ISSUES	O
=====================	O
-	O
Discharge	O
weight:	O
79.4	O
kg	O
-	O
Discharge	O
creatinine:	O
1.3	O
-	O
Please	O
weigh	O
patient	O
every	O
day.	O
Contact	O
cardiologist	O
if	O
weight	O
increases	O
by	O
more	O
than	O
3	O
pounds.	O
Discharged	O
on	O
Lasix	O
40	O
mg	O
daily;	O
this	O
may	O
require	O
uptitration.	O
-	O
Patient	O
discharged	O
on	O
insulin	O
sliding	O
scale	O
for	O
treatment	O
of	O
steroid-induced	O
hyperglycemia.	O
Insulin	O
should	O
be	O
discontinued	O
when	O
blood	O
sugars	O
normalize.	O
-	O
The	O
patient	O
should	O
use	O
BiPAP	O
at	O
night	O
and	O
has	O
needed	O
for	O
stridor	O
and	O
dyspnea	O
related	O
to	O
his	O
tracheobronchomalacia.	O
-	O
New	O
medications:	O
aspirin,	O
apixaban,	O
metoprolol	O
-	O
Patient	O
to	O
follow	O
up	O
with	O
cardiology	O
to	O
discuss	O
medical	O
management	O
of	O
CAD	O
and	O
consideration	O
of	O
high-risk	O
PCI;	O
HFpEF;	O
and	O
atrial	O
fibrillation	O
-	O
Patient	O
to	O
follow	O
up	O
with	O
pulmonology	O
to	O
discuss	O
new	O
diagnosis	O
of	O
tracheobronchomalacia	O
-	O
Communication:	O
Son	O
(___)	O
-	O
Code:	O
Full	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
may	O
be	O
inaccurate	O
and	O
requires	O
futher	O
investigation.	O
1.	O
Ipratropium-Albuterol	O
Inhalation	O
Spray	O
1	O
INH	O
IH	O
Q6H:PRN	O
dyspnea	O
2.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
3.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QAM	O
4.	O
Bisacodyl	O
10	O
mg	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
7.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
8.	O
budesonide-formoterol	O
80-4.5	O
mcg/actuation	O
inhalation	O
DAILY	O
9.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
inhalation	O
Q4H:PRN	O
10.	O
Capsaicin	O
0.025%	O
1	O
Appl	O
TP	O
TID	O
11.	O
methenamine	O
hippurate	O
1	O
gram	O
oral	O
DAILY	O
12.	O
Cyanocobalamin	O
100	O
mcg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Insulin	O
SC	O
Sliding	O
Scale	O
Fingerstick	O
QACHS	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
4.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
5.	O
albuterol	O
sulfate	O
90	O
mcg/actuation	O
inhalation	O
Q4H:PRN	O
6.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
7.	O
Bisacodyl	O
10	O
mg	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
8.	O
budesonide-formoterol	O
80-4.5	O
mcg/actuation	O
inhalation	O
DAILY	O
9.	O
Capsaicin	O
0.025%	O
1	O
Appl	O
TP	O
TID	O
10.	O
Cyanocobalamin	O
100	O
mcg	O
PO	O
DAILY	O
11.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
12.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
13.	O
Ipratropium-Albuterol	O
Inhalation	O
Spray	O
1	O
INH	O
IH	O
Q6H:PRN	O
dyspnea	O
14.	O
Lidocaine	O
5%	O
Patch	O
1	O
PTCH	O
TD	O
QAM	O
15.	O
methenamine	O
hippurate	O
1	O
gram	O
oral	O
DAILY	O
16.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY:	O
-	O
Hypoxemic	O
hypercarcbic	O
respiratory	O
failure	O
-	O
Acute	O
on	O
chronic	O
diastolic	O
heart	O
failure	O
SECONDARY:	O
-	O
Klebsiella	O
pneumonia	B-Lower_respiratory_tract_infection
-	O
Tracheobronchomalacia	O
-	O
Three-vessel	O
coronary	O
artery	O
disease	O
-	O
Steroid-induced	O
hyperglycemia	O
-	O
Atrial	O
fibrillation	O
-	O
Acute	O
kidney	O
injury	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
Please	O
see	O
below	O
for	O
information	O
on	O
your	O
time	O
in	O
the	O
hospital.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
came	O
to	O
the	O
hospital	O
to	O
have	O
a	O
procedure	O
to	O
look	O
at	O
the	O
blood	O
vessels	O
and	O
pressures	O
in	O
your	O
heart	O
WHAT	O
HAPPENED	O
IN	O
THE	O
HOSPITAL?	O
-	O
Your	O
procedure	O
showed	O
that	O
you	O
have	O
narrowing	O
in	O
several	O
vessels	O
of	O
the	O
heart	O
-	O
You	O
were	O
give	O
a	O
medicine	O
to	O
help	O
you	O
get	O
rid	O
of	O
extra	O
fluid	O
in	O
your	O
lungs	O
-	O
You	O
had	O
trouble	O
breathing	O
on	O
your	O
own,	O
so	O
a	O
breathing	O
tube	O
was	O
placed	O
to	O
help	O
you	O
breathe	O
-	O
You	O
were	O
given	O
antibiotics	O
to	O
treat	O
an	O
infection	O
in	O
your	O
lungs	O
-	O
You	O
were	O
given	O
steroids	O
to	O
help	O
with	O
inflammation	O
of	O
your	O
airway	O
-	O
You	O
breathing	O
improved,	O
and	O
you	O
were	O
eventually	O
able	O
to	O
to	O
breathe	O
comfortably	O
on	O
your	O
own	O
-	O
We	O
found	O
that	O
you	O
had	O
an	O
unusual	O
heart	O
rhythm,	O
and	O
we	O
gave	O
you	O
new	O
medicines	O
to	O
help	O
with	O
this	O
WHAT	O
SHOULD	O
I	O
DO	O
WHEN	O
I	O
GO	O
HOME?	O
-	O
You	O
should	O
weight	O
yourself	O
every	O
day	O
and	O
call	O
your	O
doctor	O
if	O
your	O
weight	O
increases	O
by	O
more	O
than	O
3	O
pounds	O
-	O
Take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
-	O
Work	O
with	O
physical	O
therapy	O
to	O
regain	O
your	O
strength	O
-	O
See	O
your	O
cardiologist,	O
Dr.	O
___,	O
to	O
talk	O
more	O
about	O
your	O
heart	O
health	O
-	O
See	O
a	O
pulmonologist	O
to	O
talk	O
more	O
about	O
your	O
lung	O
health	O
We	O
wish	O
you	O
the	O
best	O
of	O
health,	O
-Your	O
Care	O
Team	O
at	O
___	O
Followup	O
Instructions:	O
___	O

